Position in ABSI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$352,689
-$7,171,983 QoQ
Shares Held
117,563
-94.5% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. ABSI ranks #196 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,206,618 | $305,117,340 |
All Filings in ABSI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $352,689 | 117,563 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,524,672 | 2,156,067 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $214,520 | 70,566 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $140,586 | 54,703 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $87,832 | 34,993 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $76,852 | 29,333 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $97,738 | 25,586 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $78,804 | 25,586 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||